Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,303.10 +8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
Nasdaq 3,459.14 -0.27 -0.01%
Ticker Volume Price Price Delta
STOXX 50 2,764.29 -12.49 -0.45%
FTSE 100 6,654.34 -42.45 -0.63%
DAX 8,305.32 -46.66 -0.56%
Ticker Volume Price Price Delta
Nikkei 14,612.50 +128.47 0.89%
Hang Seng 22,618.70 -51.01 -0.23%
S&P/ASX 200 4,983.50 -78.95 -1.56%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

SQNM:US

4.0300 USD 0.0500 1.23%

As of 20:10:00 ET on 05/24/2013.

Company Profile for Sequenom Inc (SQNM)

Sequenom Inc. is a molecular diagnostic testing and genetics analysis company. The Company provides services, diagnostic testing, applications and genetic analysis products. Sequenom's products translate the results of genomic science into solutions for biomedical research, translational research, molecular medicine applications, and agricultural, livestock, and other areas of research.

Contact Information

Sequenom Inc

3595 John Hopkins Court
San Diego, CA 92121
United States
Phone: 1-858-202-9000
Fax: 1-858-202-9001

Key Executives for Sequenom Inc (SQNM)

Harry F Hixson JrChairman/CEOWilliam J Welch "Bill"President/COO
Paul V MaierChief Financial OfficerCharles R CantorChief Scientific Officer
Allan T BombardChief Medical OfficerDirk Van Den BoomExec VP:Rsch & Dev/CTO
Ronald M LindsayExec VP:Strategic PlanningCarolyn D BeaverVP/Chief Acctg Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil